Showing results (111-120 of 155) with videos related to
Sort By:
Pageof 16
Clinical and Laboratory Haematology|April 1, 2004
Report on slide session, British Society for Haematology, 43rd Annual Scientific Meeting, Glasgow, 2003B J Bain, J M Goldman, N P Lucie, et al.Antimicrobial Agents and Chemotherapy|September 27, 2017
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an In Vitro Infection ModelBrian D VanScoy, David Tenero, Simon Turner, et al.Antimicrobial Agents and Chemotherapy|September 20, 2021
Gepotidacin Pharmacokinetics-Pharmacodynamics against Escherichia coli in the One-Compartment and Hollow-Fiber In Vitro Infection Model SystemsBrian D VanScoy, Elizabeth A Lakota, Haley Conde, et al.Antimicrobial Agents and Chemotherapy|November 23, 2016
Pharmacokinetic-Pharmacodynamic Evaluation of Gepotidacin against Gram-Positive Organisms Using Data from Murine Infection ModelsCatharine C Bulik, Ólanrewaju O Okusanya, Elizabeth A Lakota, et al.British Journal of Haematology|August 1, 1993
Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screeningV Chowdhury, R J Olds, D A Lane, et al.Diagnostic Microbiology and Infectious Disease|March 4, 2008
Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitisPaul G Ambrose, Jack B Anon, Sujata M Bhavnani, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 16, 2018
Correction to: PK-PD Compass: bringing infectious diseases pharmacometrics to the patient's bedsideCatharine C Bulik, Justin C Bader, Li Zhang, et al.Antimicrobial Agents and Chemotherapy|December 24, 2004
Pharmacokinetics of oritavancin in plasma and skin blister fluid following administration of a 200-milligram dose for 3 days or a single 800-milligram doseGerald J Fetterly, Christine M Ong, Sujata M Bhavnani, et al.The Journal of Antimicrobial Chemotherapy|February 22, 2020
Methodological features of clinical pharmacokinetic-pharmacodynamic studies of antibacterials and antifungals: a systematic reviewAlexandra McAleenan, Paul G Ambrose, Sujata M Bhavnani, et al.European Journal of Drug Metabolism and Pharmacokinetics|February 17, 2021
Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung DiseaseChristopher M Rubino, Nikolas J Onufrak, Jakko van Ingen, et al.Pageof 16